Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.62M Buy
12,579
+310
+3% +$36.3K 0.11% 101
2026
Q1
$1.48M Sell
12,269
-87
-0.7% -$10K 0.11% 100
2025
Q4
$1.3M Buy
12,356
+5,316
+76% +$499K 0.1% 105
2025
Q3
$591K Buy
7,040
+387
+6% +$31.9K 0.05% 139
2025
Q2
$527K Buy
6,653
+2,489
+60% +$198K 0.05% 138
2025
Q1
$374K Sell
4,164
-3,950
-49% -$369K 0.04% 160
2024
Q4
$807K Sell
8,114
-1,355
-14% -$140K 0.08% 104
2024
Q3
$1.08M Sell
9,469
-467
-5% -$55.5K 0.12% 90
2024
Q2
$1.23M Sell
9,936
-181
-2% -$23.3K 0.14% 77
2024
Q1
$1.33M Sell
10,117
-738
-7% -$91K 0.15% 69
2023
Q4
$1.18M Sell
10,855
-116
-1% -$12K 0.15% 73
2023
Q3
$1.13M Buy
10,971
+255
+2% +$27.5K 0.16% 66
2023
Q2
$1.24M Buy
10,716
+1,191
+13% +$135K 0.17% 62
2023
Q1
$1.01M Sell
9,525
-1,398
-13% -$151K 0.16% 66
2022
Q4
$1.21M Buy
10,923
+359
+3% +$36.7K 0.23% 60
2022
Q3
$910K Buy
10,564
+1,321
+14% +$118K 0.2% 69
2022
Q2
$842K Buy
9,243
+3,199
+53% +$284K 0.21% 67
2022
Q1
$496K Buy
+6,044
New +$477K 0.12% 100
2021
Q1
$404K Buy
5,482
+97
+2% +$7.16K 0.14% 100
2020
Q4
$420K Buy
+5,385
New +$412K 0.17% 82

Other funds holding MRK

MBL Wealth's MRK Position: Q2 2026 in Review

MBL Wealth increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $36.3K and bringing the position to 12,579 shares worth $1.62M. The position accounts for 0.11% of the portfolio, ranked #101.

MBL Wealth first reported a position in MRK in Q4 2020 and has held it in 20 quarters since. 3,829 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • MBL Wealth held 12,579 shares of Merck worth $1.62M as of Q2 2026.
  • MBL Wealth bought 310 Merck shares in Q2 2026, an estimated $36.3K.
  • Merck made up 0.11% of MBL Wealth's portfolio in Q2 2026, its #101 holding.
  • MBL Wealth first reported a position in Merck in Q4 2020 and has held it in 20 quarters since.
  • 3,829 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on MBL Wealth's 13F filing for Q2 2026, filed 15 Jul 2026.